1. Home
  2. LXFR vs CUVL Comparison

LXFR vs CUVL Comparison

Compare LXFR & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

N/A

Current Price

$17.24

Market Cap

465.6M

Sector

Industrials

ML Signal

N/A

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

SELL

Current Price

$5.46

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

SELL

Company Overview

Basic Information
Metric
LXFR
CUVL
Founded
1898
1999
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Chemicals
Miscellaneous
Sector
Industrials
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
465.6M
374.2M
IPO Year
2002
2004

Fundamental Metrics

Financial Performance
Metric
LXFR
CUVL
Price
$17.24
$5.46
Analyst Decision
Analyst Count
0
0
Target Price
★ $16.70
N/A
AVG Volume (30 Days)
★ 427.6K
4.9K
Earning Date
10-28-2026
08-27-2026
Dividend Yield
★ 3.02%
0.58%
EPS Growth
N/A
★ N/A
EPS
★ 0.34
N/A
Revenue
★ $384,600,000.00
N/A
Revenue This Year
N/A
$0.47
Revenue Next Year
$4.99
$6.25
P/E Ratio
$50.63
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$11.26
$4.81
52 Week High
$19.45
$8.20

Technical Indicators

Market Signals
Indicator
LXFR
CUVL
Relative Strength Index (RSI) 48.47 34.32
Support Level $17.19 N/A
Resistance Level $17.38 $5.96
Average True Range (ATR) 0.04 0.26
MACD -0.01 0.02
Stochastic Oscillator 42.11 7.69

Price Performance

Historical Comparison
LXFR
CUVL

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: